CXCL13 and Pleural effusion: Although CXCL13 was found to be associated with the differentiation and staging of tumors, it cannot be fully considered as a prognostic indicator without follow-up on changes in CXCL13 levels in pleural effusions before and after treatment and on patient progression-free survival (PFS) and overall survival (OS).